Pregnancy and the pharmaceutical industry : the movement towards evidence-based pharmacotherapy for pregnant women /

Pregnancy and the Pharmaceutical Industry: The Movement towards Evidence-Based Care for Pregnant Women explores the issues surrounding the decision to undertake clinical trials with pregnant women. There is currently a lack of data on the safety and effectiveness of medications used during pregnancy...

Full description

Saved in:
Bibliographic Details
Main Authors: Shields, Kristine E.
Corporate Authors: Elsevier Science & Technology.
Published: Academic Press,
Publisher Address: London :
Publication Dates: [2019]
©2019
Literature type: eBook
Language: English
Subjects:
Online Access: https://www.sciencedirect.com/science/book/9780128185506
Summary: Pregnancy and the Pharmaceutical Industry: The Movement towards Evidence-Based Care for Pregnant Women explores the issues surrounding the decision to undertake clinical trials with pregnant women. There is currently a lack of data on the safety and effectiveness of medications used during pregnancy as it is impossible to extrapolate that information from drug studies on men and non-pregnant women. As a majority of pregnant women confront a medical condition during their pregnancy, from simple pain, to ongoing or new medical issues, this book quantifies the current absence of pregnant women in drug studies and identifies ethical issues, barriers, litigation fears and opportunities. Those in the pharmaceutical industry, IRB members who approve or deny drug study plans, doctors, nurses and midwives working in obstetrics or involved in conducting studies at their institutions will find this book an essential resource.
Carrier Form: 1 online resource : illustrations
Bibliography: Includes bibliographical references and index
ISBN: 9780128190746
0128190744
9780128185506
0128185503
Index Number: RG528
CLC: R984
Contents: Front Cover; Pregnancy and the Pharmaceutical Industry; Copyright Page; Dedication; Contents; List of figures; List of tables; Preface; Epigraph; List of abbreviations; I. The background, the debate, and the ethics involved; 1 Drug testing and pregnant women: background and significance; Background of the issue; Historical perspective; Proponents of inclusion; Significance of the issue; Ethical concerns; Aims of the book; Notes; 2 The rationales for and against inclusion; Rationales against the inclusion of pregnant women in clinical research
Rationale 1: the uncertain effect of new drugs on the mother and/or the fetus6Ethical rationale: nonmaleficence; Rationale 2: litigation risk-because birth defects are not uncommon, they may occur unrelated to experimental drug exposure ... ; Ethical rationale: financial stewardship; Rationale 3: the number of pregnant women needed to participate in the study in order to show efficacy may be unachievable; Ethical rationale: nonmaleficence; Rationale 4: safer study designs are available; Ethical rationale: beneficence; Rationale 5: alternative treatments are often available
Ethical rationale: beneficenceRationale 6: little return on investment; Ethical rationale: financial stewardship; Rationale 7: regulations do not require inclusion; Ethical rationale: financial stewardship; Rationales for the inclusion of pregnant women in clinical trials; Rationale 1: to acquire knowledge that improves the medical treatment of pregnant women and their offspring; Ethical rationale: beneficence, nonmaleficence; Rationale 2: to improve birth outcomes; Ethical rationale: beneficence, nonmaleficence
Rationale 3: to improve pregnant women's access to the benefits of clinical researchEthical rationale: justice; Rationale 4: to improve the ethical acquisition of information about exposed pregnancies; Ethical rationale: nonmaleficence, autonomy; Rationale 5: regulations do not require the exclusion of pregnant women; Ethical rationale: justice; Rationale 6: excluding pregnant women from participating in medical research is unethical and illegal-and may increase liti ... ; Ethical rationale: justice; Rationale 7: to follow the advice of experts in the field of women's health, law, and ethics
Ethical rationale: justice, nonmaleficenceNotes; 3 The ethics involved; Theoretical approaches; Principle-based ethics; The principle of respect for autonomy or respect for persons; The principles of nonmaleficence, beneficence, and the double effect; The principle of justice; Consequentialism; Feminist ethical theory; Business ethics; Special considerations for pregnancy/maternal-fetal ethics; Application of an ethical framework for studies with pregnant women; Notes; II. Quantitative and qualitative discoveries; 4 A measure of exclusion; The US clinical trial system